Literature DB >> 21244557

Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme.

Kristine K Macartney1, Mamta Porwal, Dianne Dalton, Terri Cripps, Trish Maldigri, David Isaacs, Alison Kesson.   

Abstract

AIM: To determine the impact of rotavirus immunisation on rotavirus hospitalisations in young children. methods: Annual hospitalisations for rotavirus gastroenteritis to The Children's Hospital at Westmead, a tertiary care paediatric hospital in Sydney, were recorded from 2001 for 6 years prior to and 2.5 years following the introduction of rotavirus vaccines to the National Immunisation Program. Data on hospital-acquired rotavirus gastroenteritis were collected prospectively.
RESULTS: Hospitalisations for rotavirus gastroenteritis declined in the two full rotavirus seasons (2008 and 2009) after vaccine introduction by 75% compared with mean annual hospitalisations from 2001 to 2006. The greatest decline was seen in those <12 months of age (93%), but the reduction occurred consistently across all age groups, even in children not eligible for immunisation, suggesting an effect on herd immunity. A substantial decline in nosocomial rotavirus gastroenteritis was seen from 2007 to 2009, suggesting a reduction in virus transmission in the hospital setting.
CONCLUSION: This study demonstrates a substantial reduction in hospitalisations in children of all ages to a large paediatric hospital and reduced nosocomial infections since the introduction of a nationally funded rotavirus immunisation programme in Australia.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2011        PMID: 21244557     DOI: 10.1111/j.1440-1754.2010.01953.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  13 in total

Review 1.  New insights into rotavirus vaccines.

Authors:  Chiara Mameli; Valentina Fabiano; Gian Vincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 2.  Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.

Authors:  E Anthony S Nelson; Ciro A de Quadros; Mathuram Santosham; Umesh D Parashar; Duncan Steele
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

3.  Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.

Authors:  Gary Dubin; Jean-François Toussaint; Jean-Pol Cassart; Barbara Howe; Donna Boyce; Leonard Friedland; Remon Abu-Elyazeed; Sylviane Poncelet; Htay Htay Han; Serge Debrus
Journal:  Hum Vaccin Immunother       Date:  2013-08-28       Impact factor: 3.452

4.  Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.

Authors:  Yuta Kanai; Misa Onishi; Takahiro Kawagishi; Pimfhun Pannacha; Jeffery A Nurdin; Ryotaro Nouda; Moeko Yamasaki; Tina Lusiany; Pattara Khamrin; Shoko Okitsu; Satoshi Hayakawa; Hirotaka Ebina; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

5.  Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.

Authors:  Patricia Bruijning-Verhagen; Marie-Josée J Mangen; Mariet Felderhof; Nico G Hartwig; Marlies van Houten; Léon Winkel; Wouter J de Waal; Marc J M Bonten
Journal:  BMC Med       Date:  2013-04-26       Impact factor: 8.775

6.  Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo.

Authors:  Zigang Shen; Haiyang He; Yuzhang Wu; Jintao Li
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

7.  Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells.

Authors:  James E Richards; Ulrich Desselberger; Andrew M Lever
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

8.  Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.

Authors:  Parveen Fathima; Mark A Jones; Hannah C Moore; Christopher C Blyth; Robyn A Gibbs; Thomas L Snelling
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

9.  Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models.

Authors:  Virginia E Pitzer; Katherine E Atkins; Birgitte Freiesleben de Blasio; Thierry Van Effelterre; Christina J Atchison; John P Harris; Eunha Shim; Alison P Galvani; W John Edmunds; Cécile Viboud; Manish M Patel; Bryan T Grenfell; Umesh D Parashar; Ben A Lopman
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.

Authors:  Annmarie Pendleton; Maja Galic; Christopher Clarke; Su Peing Ng; Emilio Ledesma; Gunasekaran Ramakrishnan; Yanfang Liu
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.